Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus
Year: 2017
Type: article
Source: Journal of Medicinal Chemistry
Authors: Chafiq Hamdouchi, Pranab Maiti, Alan M. Warshawsky, Amy C. DeBaillie, Keith A. Otto, Kelly L. Wilbur, Steven D. Kahl, Anjana Patel Lewis, Guemalli R. Cardona, Richard W. Zink, Keyue Chen, Siddaramaiah CR, Jayana P. Lineswala, Grace L. Neathery, Cecilia Bouaichi, Benjamin A. Diseroad, Alison N. Campbell, Stephanie A. Sweetana, Lisa A. Adams, Over Cabrera, Xiaosu Ma, Nathan P. Yumibe, Chahrzad Montrose-Rafizadeh, Yanyun Chen, Anne Reifel Miller
Institution: Eli Lilly (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2772962529